metricas
covid
Revista Colombiana de Reumatología (English Edition) Utility of anti-C1q and anti-nucleosome antibodies in systemic lupus erythematos...
Journal Information

Statistics

Follow this link to access the full text of the article

Original Investigation
Utility of anti-C1q and anti-nucleosome antibodies in systemic lupus erythematosus and lupus nephritis in southwestern Colombia
Utilidad de los anticuerpos anti-C1q y anti-nucleosomas en el lupus eritematoso sistémico y la nefritis lúpica en el suroccidente colombiano
Tatiana Méndez-Rayoa,b, Iván Posso-Osoriob, Ivana Nieto-Aristizábalb, Cristian C. Aragónb, Juan Naranjo-Escobarb, Ingrid Ruiz-Ordoñezb, Alex Echeverrib, Gloria L. Castañob,c, Carlos A. Cañasb, Carmen M. Castillob,c, Gabriel J. Tobónb,c,
Corresponding author
gtobon1@yahoo.com

Corresponding author.
a Universidad Icesi, Medical School, Cali, Colombia
b Grupo de Investigación en Reumatología, Autoinmunidad y Medicina Traslacional, Fundación Valle del Lili, Universidad Icesi, Cali, Colombia
c Laboratory of Immunology, Fundación Valle del Lili, Cali, Colombia
Read
2781
Times
was read the article
327
Total PDF
2454
Total HTML
Share statistics
Article information
ISSN: 24444405
Original language: English
The statistics are updated each day
Year/Month Html Pdf Total
2025 12 152 2 154
2025 11 117 52 169
2025 10 87 14 101
2025 9 103 36 139
2025 8 88 13 101
2025 7 127 13 140
2025 6 109 8 117
2025 5 81 3 84
2025 4 79 12 91
2025 3 81 3 84
2025 2 84 6 90
2025 1 85 0 85
2024 12 40 4 44
2024 11 33 1 34
2024 10 22 7 29
2024 9 46 5 51
2024 8 35 6 41
2024 7 25 1 26
2024 6 32 5 37
2024 5 32 2 34
2024 4 41 5 46
2024 3 37 1 38
2024 2 21 3 24
2024 1 14 1 15
2023 12 23 0 23
2023 11 28 2 30
2023 10 28 6 34
2023 9 14 2 16
2023 8 23 1 24
2023 7 27 5 32
2023 6 42 0 42
2023 5 87 4 91
2023 4 71 0 71
2023 3 57 1 58
2023 2 48 1 49
2023 1 14 5 19
2022 12 19 2 21
2022 11 21 8 29
2022 10 15 8 23
2022 9 18 7 25
2022 8 24 10 34
2022 7 16 5 21
2022 6 33 6 39
2022 5 47 7 54
2022 4 19 5 24
2022 3 24 7 31
2022 2 36 4 40
2022 1 36 4 40
2021 12 37 9 46
2021 11 38 6 44
2021 10 37 8 45
2021 9 1 1 2
Show all

Follow this link to access the full text of the article